Chemical Formula: C16H16N2O2

Chemical Formula C16H16N2O2

Found 51 metabolite its formula value is C16H16N2O2

Lysergic acid

6-Methyl-9,10-didehydroergoline-8-carboxylic acid

C16H16N2O2 (268.12117159999997)


An ergoline alkaloid comprising 6-methylergoline having additional unsaturation at the 9,10-position and a carboxy group at the 8-position.

   

Nbbcc

butyl 9H-pyrido[3,4-b]indole-3-carboxylate

C16H16N2O2 (268.1211716)


N-Butyl-beta-carboline-3-carboxylate is a member of beta-carbolines.

   
   

(+)-Lysergic acid

6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboxylic acid

C16H16N2O2 (268.12117159999997)


   

3-(1-Azatricyclo[7.3.1.05,13]trideca-5,7,9(13)-trien-7-yl)-2-cyanoprop-2-enoic acid

3-{1-azatricyclo[7.3.1.0^{5,13}]trideca-5,7,9(13)-trien-7-yl}-2-cyanoprop-2-enoic acid

C16H16N2O2 (268.12117159999997)


   

N'-Benzoyl-N,N'-dimethylbenzohydrazide

4-Amino-5-fluoro-3-phenylpentanoic acid

C16H16N2O2 (268.12117159999997)


   

Nafazatrom

3-methyl-1-[2-(naphthalen-2-yloxy)ethyl]-4,5-dihydro-1H-pyrazol-5-one

C16H16N2O2 (268.12117159999997)


C78275 - Agent Affecting Blood or Body Fluid > C29750 - Thrombolytic Agent D004791 - Enzyme Inhibitors > D016859 - Lipoxygenase Inhibitors D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents D000970 - Antineoplastic Agents D002317 - Cardiovascular Agents

   

1-(2-Benzoylphenyl)-1,3-dimethylurea

N-(2-Benzoylphenyl)-N,n-dimethylcarbamimidate

C16H16N2O2 (268.12117159999997)


   
   
   
   
   
   
   

6-methyl-8,9-didehydro-ergoline-8-carboxylic acid|6-Methyl-Delta8,9-ergolen-8-carbonsaeure|Delta8,9-Lysergsaeure|Lysergsaeure

6-methyl-8,9-didehydro-ergoline-8-carboxylic acid|6-Methyl-Delta8,9-ergolen-8-carbonsaeure|Delta8,9-Lysergsaeure|Lysergsaeure

C16H16N2O2 (268.12117159999997)


   

9-(2-Carboxy-2-cyanovinyl)julolidine

9-(2-Carboxy-2-cyanovinyl)julolidine

C16H16N2O2 (268.12117159999997)


   

4-ACETYL-4-CYANO-5-(INDOL-3-YL)PENTAN-2-ONE

4-ACETYL-4-CYANO-5-(INDOL-3-YL)PENTAN-2-ONE

C16H16N2O2 (268.12117159999997)


   

4-(1,3-benzodioxol-5-yl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

4-(1,3-benzodioxol-5-yl)-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine

C16H16N2O2 (268.12117159999997)


   

2-(2-phenylpyrrolidin-1-yl)pyridine-3-carboxylic acid

2-(2-phenylpyrrolidin-1-yl)pyridine-3-carboxylic acid

C16H16N2O2 (268.12117159999997)


   

n,n-bis(salicylidene)ethylenediamine

n,n-bis(salicylidene)ethylenediamine

C16H16N2O2 (268.12117159999997)


   

Benzoic acid,4-methyl-, 2-(4-methylbenzoyl)hydrazide

Benzoic acid,4-methyl-, 2-(4-methylbenzoyl)hydrazide

C16H16N2O2 (268.12117159999997)


   

6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine-2-carboxylic acid

6-Benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine-2-carboxylic acid

C16H16N2O2 (268.12117159999997)


   
   

2-benzyl-6-nitro-1,2,3,4-tetrahydroisoquinoline

2-benzyl-6-nitro-1,2,3,4-tetrahydroisoquinoline

C16H16N2O2 (268.12117159999997)


   
   

4-Dimethylamino-4-nitrostilbene

4-Dimethylamino-4′-nitrostilbene

C16H16N2O2 (268.12117159999997)


   

(2Z)-2-cyano-3-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)acrylic acid

(2Z)-2-cyano-3-(2,3,6,7-tetrahydro-1H,5H-pyrido[3,2,1-ij]quinolin-9-yl)acrylic acid

C16H16N2O2 (268.12117159999997)


   

N-(3-methoxyphenyl)-N-[(3-methoxyphenyl)methylidene]methanimidamide

N-(3-methoxyphenyl)-N-[(3-methoxyphenyl)methylidene]methanimidamide

C16H16N2O2 (268.12117159999997)


   

2,2-dimethyl-N-pyridin-4-yl-3H-benzofuran-7-carboxamide

2,2-dimethyl-N-pyridin-4-yl-3H-benzofuran-7-carboxamide

C16H16N2O2 (268.12117159999997)


   

5-[[2-Furanylmethyl(methyl)amino]methyl]-8-quinolinol

5-[[2-Furanylmethyl(methyl)amino]methyl]-8-quinolinol

C16H16N2O2 (268.12117159999997)


   

Acetophenone 2-methoxycarbonylphenylhydrazone

Acetophenone 2-methoxycarbonylphenylhydrazone

C16H16N2O2 (268.12117159999997)


   

(+)-Lysergic acid

6-Methyl-9,10-didehydroergoline-8-carboxylic acid

C16H16N2O2 (268.12117159999997)


   

DMeOB

DMeOB

C16H16N2O2 (268.12117159999997)


DMeOB is an agonist of mGluR5 receptor with an IC50 of 3 μM. DMeOB has a negative modulatory effect[1].

   

(5ar,11ar)-5a,11a-dimethyl-6,12-dihydro-5,11-dioxa-6,12-diazatetracene

(5ar,11ar)-5a,11a-dimethyl-6,12-dihydro-5,11-dioxa-6,12-diazatetracene

C16H16N2O2 (268.12117159999997)


   

beta-carboline-1-carboxylic acid; butyl ester

NA

C16H16N2O2 (268.12117159999997)


{"Ingredient_id": "HBIN018003","Ingredient_name": "beta-carboline-1-carboxylic acid; butyl ester","Alias": "NA","Ingredient_formula": "C16H16N2O2","Ingredient_Smile": "NA","Ingredient_weight": "268.31","OB_score": "NA","CAS_id": "153535-98-9","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "17","PubChem_id": "NA","DrugBank_id": "NA"}

   

ethyl 3-{9h-pyrido[3,4-b]indol-1-yl}propanoate

ethyl 3-{9h-pyrido[3,4-b]indol-1-yl}propanoate

C16H16N2O2 (268.12117159999997)


   

(1r)-1-{6-[(1r)-1-hydroxyethyl]phenazin-1-yl}ethanol

(1r)-1-{6-[(1r)-1-hydroxyethyl]phenazin-1-yl}ethanol

C16H16N2O2 (268.12117159999997)


   

2-[(1e)-1-{2-[1-(2-hydroxyphenyl)ethylidene]hydrazin-1-ylidene}ethyl]phenol

2-[(1e)-1-{2-[1-(2-hydroxyphenyl)ethylidene]hydrazin-1-ylidene}ethyl]phenol

C16H16N2O2 (268.12117159999997)


   

5a,11a-dimethyl-6,12-dihydro-5,11-dioxa-6,12-diazatetracene

5a,11a-dimethyl-6,12-dihydro-5,11-dioxa-6,12-diazatetracene

C16H16N2O2 (268.12117159999997)


   

(2s,6's)-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

(2s,6's)-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

C16H16N2O2 (268.12117159999997)


   

2-[(1e)-1-[(2e)-2-[1-(2-hydroxyphenyl)ethylidene]hydrazin-1-ylidene]ethyl]phenol

2-[(1e)-1-[(2e)-2-[1-(2-hydroxyphenyl)ethylidene]hydrazin-1-ylidene]ethyl]phenol

C16H16N2O2 (268.12117159999997)


   
   

(2r,7r)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),3,9,12,14-pentaene-4-carboxylic acid

(2r,7r)-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),3,9,12,14-pentaene-4-carboxylic acid

C16H16N2O2 (268.12117159999997)


   

4,6,9-trimethyl-8-methylidenepyrido[3,2-g]quinoline-2,10-diol

4,6,9-trimethyl-8-methylidenepyrido[3,2-g]quinoline-2,10-diol

C16H16N2O2 (268.12117159999997)


   
   

(2s,6'r)-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

(2s,6'r)-4-methyl-6'-(methylamino)-2'-azaspiro[furan-2,7'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),3',8'(12'),9'-tetraen-5-one

C16H16N2O2 (268.12117159999997)